Tuberc Respir Dis > Volume 67(5); 2009 > Article
Tuberculosis and Respiratory Diseases 2009;67(5):454-457.
DOI: https://doi.org/10.4046/trd.2009.67.5.454    Published online November 1, 2009.
A Case of Miliary Tuberculosis in a Patient with Behcet's Disease and Uveitis Receiving Infliximab.
Jung Wan Yoo, Jae Hyung Roh, Jin Wook Park, Yong Giun Kim, Ji Woong Jang, Soo Young Na, Tae Sun Shim
Division of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. shimts@amc.seoul.kr
Abstract
Infliximab, a TNF-alpha antagonist, has been used to treat refractory rheumatoid arthritis, ankylosing spondylitis, Crohn's disease and Behcet's disease. Tuberculosis (TB) is a well-known opportunistic infection in patients receiving infliximab. Therefore, patients should be screened and treated for latent or active TB infection before being administered infliximab. Recently, we encountered a case of military TB during infliximab therapy in a patient suffering from Behcet's disease and uveitis. We report this case with a review of the relevant literature.
Key Words: Tumor Necrosis Factor-alpha, Infliximab, Tuberculosis, Miliary


ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next